WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007009699) USE OF SUBSTITUTED PYRAZOLINE COMPOUNDS AND THEIR DERIVATIVES FOR THE TREATMENT OF CANNABINOID SYSTEM-ASSOCIATED DISEASES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/009699    International Application No.:    PCT/EP2006/006973
Publication Date: 25.01.2007 International Filing Date: 15.07.2006
IPC:
A61K 31/4155 (2006.01), A61K 31/496 (2006.01), A61K 31/454 (2006.01)
Applicants: LABORATORIOS DEL DR. ESTEVE, S.A [ES/ES]; Avda Mare de Deu de Montserrat 221, E-08041 Barcelona (ES) (For All Designated States Except US).
BUSCHMANN, Helmut, H. [DE/ES]; (ES) (For US Only)
Inventors: BUSCHMANN, Helmut, H.; (ES)
Agent: PETERS, Hajo; Bosch Graf von Stosch Jehle, Patentanwaltsgesellschaft MBH, Flüggenstrasse 13, 80639 München (DE)
Priority Data:
05384024.5 15.07.2005 EP
60/705,473 05.08.2005 US
Title (EN) USE OF SUBSTITUTED PYRAZOLINE COMPOUNDS AND THEIR DERIVATIVES FOR THE TREATMENT OF CANNABINOID SYSTEM-ASSOCIATED DISEASES
(FR) UTILISATION DE COMPOSES PYRAZOLINIQUES SUBSTITUES ET DE LEURS DERIVES CONTRE DES AFFECTIONS ASSOCIEES AU SYSTEME DES CANNABINOIDES
Abstract: front page image
(EN)The present invention relates to the use of substituted pyrazoline compounds, their derivatives as well as their physiologically acceptable salts, in medicinal products for human therapeutics and/or animal research for the treatment of a variety of diseases associated the cannabinoid receptor system in humans and animals.
(FR)La présente invention concerne l'utilisation de composés pyrazoliniques substitués, de leurs dérivés, ainsi que de certains de leurs sels physiologiquement admis, dans des produits pharmaceutiques destinés à la médecine humaine et/ou la recherche animale, pour le traitement de diverses affections associées au système des récepteurs cannabinoïdes chez les humains et autres animaux.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)